What is the current Medical Exoskeletons market size?

The Medical Exoskeletons market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Medical Exoskeletons market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Medical Exoskeletons market?

Increasing demand for rehabilitation and rising awareness of exoskeleton benefits drive the market.

What are the major challenges facing the Medical Exoskeletons market?

High costs and limited reimbursement options are significant challenges for the market.

Which regions are leading the Medical Exoskeletons market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Medical Exoskeletons market?

Top companies include Ekso Bionics, ReWalk Robotics, and Ottobock, among others.

What future opportunities exist in the Medical Exoskeletons market?

Emerging technologies and expanding applications in healthcare offer significant future opportunities.

How does technology impact the Medical Exoskeletons market?

Advances in robotics, AI, and materials science drive innovation and growth in the market.

What is the current regulatory landscape for Medical Exoskeletons?

Regulatory frameworks vary by region, with ongoing efforts to standardize and clarify guidelines.

How will the Medical Exoskeletons market evolve in the next 5 years?

The market will experience significant growth, driven by increasing adoption and technological advancements.

Medical Exoskeletons Expansion Opportunities & Forecast Analysis 2033

Medical Exoskeletons by Application (Upper Extremity Medical Exoskeletons, Lower Extremity Medical Exoskeletons), by Types (Powered Exoskeletons, Passive Exoskeletons), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Medical Exoskeletons Market Size | CAGR 12.5 Forecast 2033

Medical Exoskeletons Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1.8 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Medical Exoskeletons Market Overview

The Medical Exoskeletons market refers to the industry that designs, manufactures, and markets wearable, powered, and assistive devices that enhance or restore human movement. As the Medical Exoskeletons market size is poised for significant growth, the growth outlook and market forecast are critical for industry stakeholders to understand the industry expansion. The scope of this market encompasses various types of exoskeletons, including powered and non-powered, as well as their applications in rehabilitation, military, and industrial settings. The current Medical Exoskeletons market size is approximately $272 million, with a projected growth outlook of 22.1% CAGR during the forecast period from 2026 to 2033, driven by macro drivers such as advancements in technology, increasing demand for rehabilitation devices, and rising awareness about exoskeletons.

Loading chart…

Key forces shaping the Medical Exoskeletons market include technology shifts towards advanced materials and sensor technologies, regulations and standards for exoskeleton safety and efficacy, and changing consumer behavior towards adoption of assistive devices. The largest region in the Medical Exoskeletons market is North America, while the fastest-growing region is Asia Pacific, driven by increasing demand for rehabilitation devices and rising investments in exoskeleton technology. As the Medical Exoskeletons market continues to evolve, industry stakeholders must stay informed about the latest trends, opportunities, and challenges to remain competitive and capitalize on the industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	4.62 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cyberdyne; Ekso Bionics; ReWalk Robotics; Bionik Laboratories; Rex Bionics; Parker Hannifin; B-Temia; Bioness; Hocoma; Wearable Robotics; Gogoa Mobility Robots; Exoatlet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Exoskeletons market is poised for significant growth, driven by technological advancements and increasing demand for rehabilitation and assistive devices. The Medical Exoskeletons market size is expected to expand substantially over the forecast period, with a promising growth forecast.

Growth Drivers2 items

Advances in materials science and artificial intelligence are enabling the development of more sophisticated and affordable Medical Exoskeletons, driving adoption rates and contributing to the growth of the Medical Exoskeletons market

Government initiatives and investments in rehabilitation technologies are creating new opportunities for Medical Exoskeletons manufacturers, further fueling the growth forecast of the Medical Exoskeletons market

Restraints2 items

High development costs and regulatory hurdles are limiting the entry of new players in the Medical Exoskeletons market, potentially constraining the Medical Exoskeletons market size

Concerns over patient safety and device efficacy are leading to increased scrutiny of Medical Exoskeletons, which may impact the growth forecast of the Medical Exoskeletons market

Opportunities2 items

The growing demand for personalized medicine and customizable Medical Exoskeletons is creating new opportunities for manufacturers to develop tailored solutions, driving the Medical Exoskeletons market forward

Partnerships between Medical Exoskeletons manufacturers and rehabilitation centers are enabling the development of more effective treatment protocols, contributing to the growth of the Medical Exoskeletons market

Challenges2 items

The Medical Exoskeletons market faces significant competition from alternative technologies, such as brain-computer interfaces, which may impact the growth forecast of the Medical Exoskeletons market

Ensuring the cybersecurity of Medical Exoskeletons is a major challenge, as connected devices pose a risk to patient data and safety, potentially affecting the Medical Exoskeletons market size

Market Segmentation

Loading chart…

The Application segment of the Medical Exoskeletons market is divided into subcategories, each contributing to the overall market size. This segmentation is crucial for understanding the Medical Exoskeletons segmentation and its various uses. The main applications include rehabilitation, assistive, and military, with rehabilitation being the largest segment. This is due to the increasing demand for exoskeletons in rehabilitation centers to help patients with physical disabilities or injuries.

The Types segment of the Medical Exoskeletons market comprises subtypes such as powered exoskeletons and non-powered exoskeletons. Powered exoskeletons are further divided into active and passive exoskeletons. Non-powered exoskeletons, on the other hand, include passive and orthotic exoskeletons. Each subtype has its own unique characteristics and contributes to the overall market size. Understanding these subtypes is essential for analyzing the market taxonomy and identifying areas of growth and opportunity.

Medical Exoskeletons Segmentation Breakdown6 items

Application

Upper Extremity Medical Exoskeletons

Lower Extremity Medical Exoskeletons

Types

Powered Exoskeletons

Passive Exoskeletons

Regional Insights

Loading chart…

The Medical Exoskeletons market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of medical exoskeletons, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and significant investments in research and development. In Europe, drivers include favorable policies, a strong infrastructure, and a high level of adoption. Asia Pacific is driven by a large and growing demographics, increasing adoption, and significant investments in healthcare. Latin America and Middle East & Africa are driven by growing demographics, increasing adoption, and improving infrastructure.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing adoption of medical exoskeletons in countries such as China and Japan. North America and Europe will continue to dominate the market, driven by their mature ecosystems and high levels of adoption. Latin America and Middle East & Africa will experience moderate growth, driven by improving infrastructure and increasing adoption.

Competitive Landscape

The Medical Exoskeletons market exhibits a moderately consolidated structure, characterized by the presence of both global players and local/regional companies. The Medical Exoskeletons competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including technology, service model, channel strength, customization, and cost advantages. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies must navigate these challenges while maintaining a strong focus on innovation and customer needs.

Cyberdyne: regional expansion

Ekso Bionics: innovation pipeline

ReWalk Robotics: premium pricing

Bionik Laboratories: OEM tie-ups

Rex Bionics: local manufacturing

Parker Hannifin: vertical integration

Key Medical Exoskeletons Companies12 items

Cyberdyne

Ekso Bionics

ReWalk Robotics

Bionik Laboratories

Rex Bionics

Parker Hannifin

B-Temia

Bioness

Hocoma

Wearable Robotics

Gogoa Mobility Robots

Exoatlet

Market Ecosystem

The Medical Exoskeletons ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three primary tiers: upstream, midstream, and downstream. The upstream segment comprises technology providers and suppliers, while the midstream segment includes integrators and manufacturers. The downstream segment, in turn, encompasses channels, such as distributors and service providers, and ultimately, the end users. Value is created and captured as innovative technologies and components are integrated into medical exoskeletons, which are then distributed and serviced to meet the needs of end users.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and produce medical exoskeletons

Technology providers — develop enabling technologies

System integrators / EPCs — integrate exoskeleton systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish and enforce safety standards

Within the Medical Exoskeletons ecosystem, control points are largely influenced by regulators and standards bodies, as well as by the technology providers and manufacturers that drive innovation. Dependency risks arise from input constraints, such as the availability of critical components, and from the need for regulatory approvals. Switching costs and partnerships are also significant, as companies may need to invest heavily in new technologies or form partnerships to ensure interoperability. Furthermore, the ecosystem may differ by region due to variations in regulatory frameworks, healthcare systems, and market demand, highlighting the need for a nuanced understanding of the Medical Exoskeletons ecosystem through a detailed value chain analysis.

Recent Industry Insights

The Medical Exoskeletons industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as collaborations between exoskeleton manufacturers and rehabilitation centers, have been formed to advance the technology and increase accessibility. Furthermore, there have been key mergers and acquisitions, including the acquisition of smaller exoskeleton startups by established players, aiming to expand product portfolios and reinforce market positions.

In addition to these strategic moves, several companies have launched new products and technologies, enhancing the capabilities and user experience of medical exoskeletons. Regulatory changes have also supported the growth of the industry, with approvals and clearances for various exoskeleton devices. Moreover, there has been a shift in consumer and enterprise trends, with an increased focus on rehabilitation and assistive technologies. Funding rounds and expansions have also been observed, with investors showing interest in the potential of medical exoskeletons to transform the lives of individuals with disabilities.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Medical Exoskeletons market outlook. The market attractiveness is high due to the growing demand for rehabilitation and assistive technologies. The competitive intensity is moderate, with key players dominating the market, but new entrants are expected to increase competition. The long-term outlook is positive, driven by advancements in technology and increasing adoption in the healthcare sector.

The innovation landscape is evolving rapidly, with a focus on developing more affordable and user-friendly exoskeletons. The demand–supply balance is expected to be stable, with suppliers catering to the growing demand. However, key risk factors include regulatory challenges and high development costs. Overall, the Medical Exoskeletons market outlook is promising, with opportunities for growth and innovation.

11 items

1. Executive Summary

2. Medical Exoskeletons Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Exoskeletons Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Exoskeletons Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Upper Extremity Medical Exoskeletons

6.1.2. Lower Extremity Medical Exoskeletons

6.2. Global Medical Exoskeletons Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Powered Exoskeletons

6.2.2. Passive Exoskeletons

6.3. Global Medical Exoskeletons Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Exoskeletons Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Exoskeletons Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Exoskeletons Market Competition by Key Manufacturers

8.1. Global Medical Exoskeletons Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Exoskeletons: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cyberdyne

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Ekso Bionics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ReWalk Robotics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bionik Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Rex Bionics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Parker Hannifin

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. B-Temia

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bioness

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hocoma

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Wearable Robotics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Gogoa Mobility Robots

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Exoatlet

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Exoskeletons Market

Figure 4: Global Medical Exoskeletons Market: Drivers

Figure 5: Global Medical Exoskeletons Market: Challenges

Figure 6: Global Medical Exoskeletons Market: Trends

Figure 7: Global Medical Exoskeletons Market: Opportunity

Figure 8: Global Medical Exoskeletons Market: Restraint

Figure 9: Global Medical Exoskeletons Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Exoskeletons Market Value (USD Million) By Region

Figure 15: Global Medical Exoskeletons Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Exoskeletons Market Value (USD Million) By Region

Figure 23: Global Medical Exoskeletons Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Exoskeletons Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Exoskeletons Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Exoskeletons Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Exoskeletons Market Value (USD Million) By Region

Table 10: Global Medical Exoskeletons Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Exoskeletons Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Exoskeletons Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Exoskeletons Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cyberdyne Basic Information And Sales Area

Table 31: Cyberdyne. Products Portfolio

Table 32: Ekso Bionics Basic Information And Sales Area

Table 33: Ekso Bionics. Products Portfolio

Table 34: ReWalk Robotics Basic Information And Sales Area

Table 35: ReWalk Robotics. Products Portfolio

Table 36: Bionik Laboratories Basic Information And Sales Area

Table 37: Bionik Laboratories. Products Portfolio

Table 38: Rex Bionics Basic Information And Sales Area

Table 39: Rex Bionics. Products Portfolio

Table 40: Parker Hannifin Basic Information And Sales Area

Table 41: Parker Hannifin. Products Portfolio

Table 42: B-Temia Basic Information And Sales Area

Table 43: B-Temia. Products Portfolio

Table 44: Bioness Basic Information And Sales Area

Table 45: Bioness. Products Portfolio

Table 46: Hocoma Basic Information And Sales Area

Table 47: Hocoma. Products Portfolio

Table 48: Wearable Robotics Basic Information And Sales Area

Table 49: Wearable Robotics. Products Portfolio

Table 50: Gogoa Mobility Robots Basic Information And Sales Area

Table 51: Gogoa Mobility Robots. Products Portfolio

Table 52: Exoatlet Basic Information And Sales Area

Table 53: Exoatlet. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Medical Exoskeletons Market Value (USD Million) By Region

Table 59: Global Medical Exoskeletons Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Exoskeletons Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.80 million
Revenue forecast in 2033	4.62 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cyberdyne; Ekso Bionics; ReWalk Robotics; Bionik Laboratories; Rex Bionics; Parker Hannifin; B-Temia; Bioness; Hocoma; Wearable Robotics; Gogoa Mobility Robots; Exoatlet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options